AzTrials
AzTrials

Myotonic Dystrophy 1CABLAMYDNCT04712422

Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1

An observational study of Myotonic Dystrophy 1, run by Istituto Auxologico Italiano at 2 sites in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Impairment of balance and gait are frequent complaints in patients with myotonic dystrophy type 1 (DM1). In these persons, there is an increased risk for stumbles and falls when compared to normal subjects. An underestimated cause of falls might be the weakness of neck flexor muscles (due to cervical ataxia). Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Myotonic Dystrophy 1
What is being tested?
Healthy subjects and Pathologic group
How many people
42 participants
Where
2 sitesItaly
Study dates
27 Oct 2020to 31 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: The participants will be recruited in the NeuroMuscolar Omniservice (NEMO) clinical centre, on an outpatient basis, from a physiatric referral, or from an inpatient rehabilitation unit.

Who may be able to join

  • Diagnosis of DM1 since at least 5 years;
  • Ability to stand erect with open eyes for at least 20 s;
  • Rivermead Mobility Index (RMI) score ≥ 10/15;
  • Visual acuity > 10/20, also with corrective lenses;
  • Mini Mental State Examination (MMSE) score ≥ 26/30;
  • ability to wittingly sign the informed consent form.

Who cannot join

  • neurological or orthopedic pathologies with impact on balance;
  • pregnancy;
  • previous orthopedic surgical intervention;
  • head or neck trauma in the 6 months preceding the study;
  • other pathological conditions which could alter balance;
  • drug therapy, underway for less than one month before the study, with impact on balance.

Trial locations and contacts

2 sites in 1 country.

Italy2 sites
  • Istituto Auxologico Italiano

    Milan, MI, 20121

  • The NEuroMuscular Omnicentre (NEMO) Clinical Center

    Milan, MI, 20162

Other trials in Italy

About this study

Impairment of balance and gait are frequent complaints in patients with myotonic dystrophy type 1 (DM1). In these persons, there is an increased risk for stumbles and falls when compared to normal subjects. An underestimated cause of falls might be the weakness of neck flexor muscles (due to cervical ataxia). It is well known that fibres of muscle spindles are receptors combining a specialized sub-set of muscle fibers with a specialized array of both sensory and motor nerve fibers. Spindles transduce into neural afferent discharges the muscle length and length changes. They are very dense in deep neck muscles, are crucial to body balance and gage orientation, and are severely affected in DM1. Preliminary results suggest that falls could reflect imbalance. These indicate that cervical ataxia may come into play because of muscle spindle fibre disruption. In light of the current knowledge on the physiology of balance and on the association between balance deficits and cervical dystonia in other clinical conditions (e.g., whiplash injury), a rationale is therefore offered to a confirmation of the hypothesis that DM1 patients may suffer from cervical ataxia.

The primary endpoint is the demonstration of an association between balance deficits in standing and cervical proprioception deficit in adults affected by Myotonic dystrophy 1.

Read more

Secondary endpoints are:

  • the investigation of the correlation among the two deficits and the clinical conditions of patients,
  • the definition of normative data in the measure of cervical proprioception in a sample of healthy participants.

It is expected that high scores in postural balance, obtained on the posturographic Equitest™-Sensory Organization Test-SOT, correspond to high levels of repositioning accuracy in tests of cervical repositioning and low SOT scores correspond to low accuracy. Moreover, it is expected that an association exists among the two deficits and the clinical situation of the patients. Results from the present pilot study will allow an estimate of the sample size for future experimental protocols. The evidence for an association between balance deficits and cervical ataxia would be of obvious relevance to the patients. This would also support the hypothesis that neck muscle spindles may be especially affected in DM1. This would highlight that muscles are also crucial sensory organs, involved in the perception of joint position, muscle strength, and fatigue. Results from the present study might allow the definition of new rehabilitative programs, such as treatments through a neck strengthening (and thus stiffening) exercise program. This study, therefore, might stimulate new research hypothesis at the neurophysiologic level and possibly lead to findings generalizable from DM1 to other forms of myopathy.

Being tested
Healthy subjects, Pathologic group
Keywords
Myotonic Dystrophy 1, Accidental falls, Ataxia, Postural balance, Rehabilitation
Medical subject headings
Myotonic Dystrophy, Ataxia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Healthy subjectsOther

    Participants will be tested for their foot dominance by means of the Waterloo footedness questionnaire-revised, their hand dominance by means of the Edinburgh inventory, and their eyedness Coren's Lateral Preference Inventory.

    Participants will perform a cervical repositioning test. They will seat in a chair in front of a Plexiglas screen with the eye closed. The operator will guide the participant in four positions: at 30° right/left rotation and at 25° extension/flexion. The participant will be then asked to reproduce the angle. Each movement will be repeated four times in a random order. The whole sequence will be repeated by another second operator. Both the tests will be repeated after two weeks.

    Head movements will be detected using an optoelectronic system using passive markers positioned on the head of the participant.

  • Pathologic groupOther

    Clinical evaluation of the participants will be performed by means of the Myotonic Dystrophy Health Index (MDHI), the Rivermead Mobility Index (RMI), the Fall Events Questionnaire, and the Dizziness Handicap Inventory- short form (DHIsf).

    Participants will perform a cervical repositioning test. Participants will seat in a chair in front of a Plexiglas screen with the eye closed. The operator will guide the participant in four positions: at 30° right/left rotation and at 25° extension/flexion. The participant will be then asked to reproduce the angle. Each movement will be repeated four times in a random order.

    Head movements will be detected using an optoelectronic system using passive markers positioned on the head of the participant.

    Participants will then perform test of balance in standing, using the EquiTest platform. Individuals will be requested to perform three different tasks: sensory organization test, adaptation test-upward tilt, and adaptation test-downward tilt.

Study groups in NCT04712422
Study groupRoleWhat they receive
Healthy participantsAt least 25 healthy participants aged from 18 to 50 years old. Participants will be excluded if pregnant.
Receives: Other: Healthy subjects
Pathologic groupAt least 22 participants with diagnosis of Myotonic Dystrophy 1.
Receives: Other: Pathologic group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. SOT score

    The patient's task is to maintain an upright stance during 3 20 s trials under six different conditions, including platform and visual surround 'tuned' with individual's sagittal oscillation. The SOT score will be calculated by comparing the sagittal oscillation of the body's centre of mass (COM) to the maximal sagittal oscillation. Score is averaged across the six conditions (range 0 - 100 the higher the score, the lower the oscillation).

    Measured: Day 1

Secondary outcomes (1)
  1. Head Repositioning Accuracy, HRA

    The head repositioning accuracy in percentage will be computed as the joint position error (JPE) divided by the target position. The JPE will be computed as the absolute difference between the target position and the measured position.

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2021
  2. Study start27 Oct 2020
  3. Primary completion13 Oct 2021
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04712422
Sponsor's protocol ID
24C020
Acronym
CABLAMYD
Status last verified
Feb 2024
First submitted
13 Jan 2021
Last updated
20 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Galli M, Cimolin V, Crugnola V, Priano L, Menegoni F, Trotti C, Milano E, Mauro A. Gait pattern in myotonic dystrophy (Steinert disease): a kinematic, kinetic and EMG evaluation using 3D gait analysis. J Neurol Sci. 2012 Mar 15;314(1-2):83-7. doi: 10.1016/j.jns.2011.10.026. Epub 2011 Nov 25.

    PubMed 22118863
  • Jimenez-Moreno AC, Raaphorst J, Babacic H, Wood L, van Engelen B, Lochmuller H, Schoser B, Wenninger S. Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey. Neuromuscul Disord. 2018 Mar;28(3):229-235. doi: 10.1016/j.nmd.2017.12.010. Epub 2017 Dec 27.

    PubMed 29361394
  • Pieterse AJ, Luttikhold TB, de Laat K, Bloem BR, van Engelen BG, Munneke M. Falls in patients with neuromuscular disorders. J Neurol Sci. 2006 Dec 21;251(1-2):87-90. doi: 10.1016/j.jns.2006.09.008. Epub 2006 Nov 9.

    PubMed 17097113
  • Hammaren E, Kjellby-Wendt G, Kowalski J, Lindberg C. Factors of importance for dynamic balance impairment and frequency of falls in individuals with myotonic dystrophy type 1 - a cross-sectional study - including reference values of Timed Up & Go, 10m walk and step test. Neuromuscul Disord. 2014 Mar;24(3):207-15. doi: 10.1016/j.nmd.2013.12.003. Epub 2013 Dec 15.

    PubMed 24412157
  • Proske U, Gandevia SC. The proprioceptive senses: their roles in signaling body shape, body position and movement, and muscle force. Physiol Rev. 2012 Oct;92(4):1651-97. doi: 10.1152/physrev.00048.2011.

    PubMed 23073629
  • Sansone VA, Lizio A, Greco L, Gragnano G, Zanolini A, Gualandris M, Iatomasi M, Heatwole C. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure. Neuromuscul Disord. 2017 Nov;27(11):1047-1053. doi: 10.1016/j.nmd.2017.07.004. Epub 2017 Jul 10.

    PubMed 28890289
  • Tesio L, Alpini D, Cesarani A, Perucca L. Short form of the Dizziness Handicap Inventory: construction and validation through Rasch analysis. Am J Phys Med Rehabil. 1999 May-Jun;78(3):233-41. doi: 10.1097/00002060-199905000-00009.

    PubMed 10340421
  • Tesio L, Rota V, Longo S, Grzeda MT. Measuring standing balance in adults: reliability and minimal real difference of 14 instrumental measures. Int J Rehabil Res. 2013 Dec;36(4):362-74. doi: 10.1097/MRR.0000000000000037.

    PubMed 24185405
  • Beinert K, Taube W. The effect of balance training on cervical sensorimotor function and neck pain. J Mot Behav. 2013;45(3):271-8. doi: 10.1080/00222895.2013.785928.

    PubMed 23663191
  • Loudon JK, Ruhl M, Field E. Ability to reproduce head position after whiplash injury. Spine (Phila Pa 1976). 1997 Apr 15;22(8):865-8. doi: 10.1097/00007632-199704150-00008.

    PubMed 9127919
  • Grip H, Sundelin G, Gerdle B, Karlsson JS. Variations in the axis of motion during head repositioning--a comparison of subjects with whiplash-associated disorders or non-specific neck pain and healthy controls. Clin Biomech (Bristol). 2007 Oct;22(8):865-73. doi: 10.1016/j.clinbiomech.2007.05.008. Epub 2007 Jul 9.

    PubMed 17619066
  • Ferrario VF, Sforza C, Serrao G, Grassi G, Mossi E. Active range of motion of the head and cervical spine: a three-dimensional investigation in healthy young adults. J Orthop Res. 2002 Jan;20(1):122-9. doi: 10.1016/S0736-0266(01)00079-1.

    PubMed 11853078
  • Mortensen JD, Vasavada AN, Merryweather AS. The inclusion of hyoid muscles improve moment generating capacity and dynamic simulations in musculoskeletal models of the head and neck. PLoS One. 2018 Jun 28;13(6):e0199912. doi: 10.1371/journal.pone.0199912. eCollection 2018.

    PubMed 29953539
  • Vasavada AN, Hughes E, Nevins DD, Monda SM, Lin DC. Effect of Subject-Specific Vertebral Position and Head and Neck Size on Calculation of Spine Musculoskeletal Moments. Ann Biomed Eng. 2018 Nov;46(11):1844-1856. doi: 10.1007/s10439-018-2084-9. Epub 2018 Jul 9.

    PubMed 29987540
  • Vasavada AN, Li S, Delp SL. Influence of muscle morphometry and moment arms on the moment-generating capacity of human neck muscles. Spine (Phila Pa 1976). 1998 Feb 15;23(4):412-22. doi: 10.1097/00007632-199802150-00002.

    PubMed 9516695

Questions about this trial

What is this clinical trial studying?

An observational study of Myotonic Dystrophy 1, run by Istituto Auxologico Italiano at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

SOT score (time frame: Day 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04712422, which also lists 16 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in